𝔖 Bobbio Scriptorium

✦ LIBER ✦

Starting IFN-β-1a therapy at the time of the first demyelinating event beneficial in patients at high risk of MS

Book ID: 120867701
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2000
Weight: 150 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200012580-00034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Should we measure C-reactive protein lev

Should we measure C-reactive protein levels to ascertain the adequacy of statin therapy in patients who are at very high risk for a coronary heart disease event?

✍ Abhinav Goyal; Michael Blazing 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Low-dose metoprolol CR/XL and fluvastati

Low-dose metoprolol CR/XL and fluvastatin slowed progression of carotid atherosclerosis in asymptomatic patients with carotid plaque: Ramipril had a beneficial effect on the progression of atherosclerosis in patients at high risk for cardiovascular events

✍ Curt D. Furberg; Gregory W. Evans 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 252 KB

Rationale and design of the LEADERS FREE

Rationale and design of the LEADERS FREE trial: A randomized double-blind comparison of the BioFreedom drug-coated stent vs the Gazelle bare metal stent in patients at high bleeding risk using a short (1 month) course of dual antiplatelet therapy

✍ Urban, Philip; Abizaid, Alex; Chevalier, Bernard; Greene, Samantha; Meredith, Ia 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 237 KB